CClinicalTrials.gg
CompletedNCT03166319Updated Mar 17, 2022

Vessel Wall Imaging for Diagnosis and Monitoring of Central Nervous System (CNS) Vasculitis

An interventional study of MRI, including intracranial vessel wall imaging in Vasculitis, CNS and Vasculitis, Cerebral, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-17.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective pilot study to determine the utility of MRI and high resolution intracranial vessel wall imaging for the diagnosis and disease activity assessment of intracranial vasculitis.

Read the detailed description

This study will evaluate patients with suspected primary angiitis of the central nervous system (PACNS), recruited during initial work-up by our multi-disciplinary team. Given the low incidence of CNS vasculitis and the fact that some patients are routed to a quaternary care center after initial work-up and diagnosis, evaluation of both groups will be useful to maximize the number of participants evaluated and to provide a representative sample of patients typically treated. During the study, participants will ultimately be deemed to have;

  1. A specific clinical and pathologic subtype of PACNS,
  2. PACNS not otherwise specified (NOS) without pathologic or clinical proof of a specific subtype, or
  3. An alternative diagnosis other than PACNS.

Patients will undergo a standardized imaging and clinical examination at presentation and at pre-defined follow-up periods. Imaging examinations will include an MRI of the head, standard magnetic resonance angiogram (MRA) of the head, and intracranial vessel wall imaging without and with IV gadolinium. Patients will receive up to 4 imaging examinations at predefined intervals as part of this study. MRI/MRA/Vessel wall features will be evaluated by 2 neuroradiologists. Imaging findings will be correlated to clinical and any available laboratory or pathologic data. The target accrual is 10 patients for this pilot study.

02

Conditions studied

  • Vasculitis, CNS
  • Vasculitis, Cerebral

Browse trials for

03

In context

Vasculitis

230 studies on the registry are indexed under Vasculitis; 68 are open to participants now.

This study's enrollment of 15 is below the median of 48 across 119 interventional studies indexed under Vasculitis.

Browse Vasculitis studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. The patient is determined to have suspected PACNS upon evaluation by a neurologist or rheumatologist or may have an established diagnosis of PACNS of any duration as determined by a neurologist or rheumatologist.
  2. Ability to undergo routine clinical testing, including lumbar puncture performed for PACNS to exclude potential alternative diagnoses (for initial suspected cases).
  3. Ability to provide informed consent.

Exclusion criteria

Exclusion Criteria:

  1. Less than 18 years of age.
  2. Any absolute contraindication to 3 Tesla MRI.
  3. Any absolute contraindication to gadolinium.
  4. Contraindication to lumbar puncture such as severe coagulopathy.
  5. High risk carotid atherosclerotic plaque defined as either greater than 70% stenosis or known high risk plaque features such as intra-plaque hemorrhage.
  6. Medium or high risk factors for cardioembolic stroke based on the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Suspected CNS Vasculitis

    Patients with suspected CNS vasculitis will undergo an MRI, including intracranial vessel wall imaging.

    Diagnostic Test: MRI, including intracranial vessel wall imaging

Interventions

  • Diagnostic testMRI, including intracranial vessel wall imaging

    MRI/MRA/intracranial high-resolution vessel wall imaging (HR-VWI)

06

What researchers measure

Primary outcomes

  1. Number of Subjects with Diagnosis of Stroke

    Clinical or MRI evidence of stroke on follow-up exam.

    Time frame: Approximately 5 months after baseline

07

Study locations

1 site
  • Mayo Clinic
    Rochester, Minnesota 55902, United States
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 17, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03166319
Lead sponsor
Mayo Clinic
Responsible party
Vance Lehman (Assistant Professor of Radiology, Mayo Clinic, Mayo Clinic) — Principal investigator
First posted
May 25, 2017
Start date
Jul 24, 2017
Primary completion
Nov 24, 2020
Completion
Nov 24, 2020
Last update
Mar 17, 2022

Study contacts

Vance Lehman, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion